|
Rapamycin in bloomberg.com as an anti-ageing drug. |
 |
 |
|
Bloomberg: Over the past decade, it’s shown promise as a drug that not only can extend life by delaying the onset of aging-related diseases such as cancer, heart disease, and Alzheimer’s disease, but also postpone the effects of normal aging. With an eye toward changing the way millions grow older, Novartis, the $260 billion Swiss pharmaceutical giant, has begun taking the first steps to position a version of rapamycin as the first true anti-aging drug.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
